The UK has an advantage in conducting clinical trials in that everyone is insured and receives treatment through National Health Services (NHS). The NHS is the largest single healthcare provider in the world. With more than 4,000 life sciences companies in the UK, Great Britain’s life sciences cluster is well-poised to offer this innovative program to Israeli’s bio, pharma, and medical device companies.
Image of the Month
Synthesizing and Consolidation of Mechanically-Induced Solid-State Reacted Ti50C50 Nanopowders and Subsequent Consolidations
BFI of the powders obtained after 5 h of the ball milling time
Nanotechnology and Advanced Materials Program, Energy and Building Research Center, Kuwait Institute for Scientific Research, Kuwait
NSTI Online Community